文献速递神经肿瘤

经蝶窦应用Liqoseal预防脑脊液漏的离体与在体评估

Ex vivo and in vivo evaluation of transsphenoidal Liqoseal application to prevent cerebrospinal fluid leakage.
PubMed 文献 · Acta Neurochir (Wien) · 2023-01-09

本研究通过离体模型评估Liqoseal在模拟蝶窦解剖条件下的爆破压力,并描述3例经蝶窦手术中术中脑脊液漏患者应用Liqoseal的情况。离体总体平均爆破压力为231(±103)mmHg,不同应用重量和时间组间无显著差异(p=0.227);在体3例患者术后均无脑脊液漏,1例出现术后脑膜炎和脑室炎,可能与术前广泛脑脊液漏有关。作者认为内镜经蝶窦手术中应用Liqoseal封闭硬膜缺损可能安全且潜在有效。

要点

  • 离体模拟蝶窦解剖条件下,Liqoseal总体平均爆破压力为231(±103)mmHg。
  • 离体不同应用重量和时间组间平均爆破压力无显著差异(p=0.227)。
  • 3例经蝶窦术中脑脊液漏患者应用Liqoseal后术后均无脑脊液漏。

核心结论

  • 作者评估内镜经蝶窦手术中应用Liqoseal封闭硬膜缺损可能安全且潜在有效。

研究设计与样本

  • 离体实验:建立模拟蝶窦解剖的装置,使用流体泵和猪硬膜置于具有蝶鞍解剖尺寸的锥体上,评估Liqoseal应用于膨隆表面的爆破压力;因经蝶窦环境具有挑战性,分4组测试不同压缩重量和时间下应用Liqoseal的爆破压力。
  • 在体部分:描述3例经蝶窦手术中发生术中脑脊液漏的患者应用Liqoseal以预防术后脑脊液漏。

主要发现

  • 离体经蝶窦装置中总体平均爆破压力为231(±103)mmHg。
  • 离体基于应用重量和时间的分组间平均爆破压力无显著差异(p=0.227)。
  • 在体3例患者均无术后脑脊液漏,未观察到鼻道问题。
  • 1例患者出现术后脑膜炎和脑室炎,最可能与术前广泛脑脊液漏相关。
  • 术后影像未显示任何局部感染、肿胀或其他器械相关不良事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite improvements in closure techniques by using a vital nasoseptal flap, the use of sealing materials, and improved neurosurgical techniques, cerebrospinal fluid (CSF) leak after transsphenoidal surgery still is a clinically relevant problem. Liqoseal® (Polyganics bv, Groningen, The Netherlands) is a CE-approved bioresorbable sealant patch for use as an adjunct to standard methods of cranial dural closure to prevent CSF leakage. This study aims to evaluate the application of Liqoseal in transsphenoidal surgery ex vivo and in vivo. METHODS: 1. We created an ex vivo setup simulating the sphenoidal anatomy, using a fluid pump and porcine dura positioned on a conus with the anatomical dimensions of the sella to evaluate whether the burst pressure of Liqoseal applied to a bulging surface was above physiological intracranial pressure. Burst pressure was measured with a probe connected to dedicated computer software. Because of the challenging transsphenoidal environment, we tested in 4 groups with varying compression weight and time for the application of Liqoseal. 2. We subsequently describe the application of Liqoseal® in 3 patients during transsphenoidal procedures with intraoperative CSF leakage to prevent postoperative CSF leakage. RESULTS: 1. Ex vivo: The overall mean burst pressure in the transsphenoidal setup was 231 (± 103) mmHg. There was no significant difference in mean burst pressure between groups based on application weight and time (p = 0.227). 2. In Vivo: None of the patients had a postoperative CSF leak. No nose passage problems were observed. One patient had a postoperative meningitis and ventriculitis, most likely related to preoperative extensive CSF leakage. Postoperative imaging did not show any local infection, swelling, or other device-related adverse effects. CONCLUSIONS: We assess the use of Liqoseal® to seal a dural defect during an endoscopic transsphenoidal procedure as to be likely safe and potentially effective.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Slot EMH, Colmer N, Serra C, et al. Ex vivo and in vivo evaluation of transsphenoidal Liqoseal application to prevent cerebrospinal fluid leakage. Acta Neurochir (Wien). 2023. PMID: 36624231. doi:10.1007/s00701-022-05477-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。